Associated Papers
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Zhang C et al.
Cell Reports. Medicine, 2024
38897205 (PubMed )
Supplement: mmc10.xlsx › Sheet1
The genetic landscape of 5T models for multiple myeloma.
Maes K et al.
Scientific Reports, 2018
30301958 (PubMed )
Supplement: 41598_2018_33396_MOESM2_ESM.xlsx › supplementary_table_7
Select a paper to view details